Abstract |
Ten patients infected with mouse proven DDS-resistant bacilli were treated with the following combined regimen: RMP 600 2/7 6 months, ETH 500 7/7 6 months and DDS 100 7/7 12 months. Follow up was for 27-54 months, without relapses. Added to patients from previous study (Int. J. Lepr. 1984, 52, 297-303) the 95% confidence limit decreases from 12 to 9%.
|
Authors | S R Pattyn, J A Husser, P Saint-André |
Journal | Acta leprologica
(Acta Leprol)
1986 Oct-Dec
Vol. 4
Issue 4
Pg. 445-6
ISSN: 0001-5938 [Print] Switzerland |
Vernacular Title | Efficacité de traitements combinés comportant six mois d'administration de rifampicine dans la lèpre multibacillaire. |
PMID | 3296614
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Dapsone
- Ethionamide
- Rifampin
|
Topics |
- Dapsone
(therapeutic use)
- Drug Therapy, Combination
- Ethionamide
(therapeutic use)
- Humans
- Leprosy
(drug therapy)
- Rifampin
(therapeutic use)
|